Conference
Anti Tumor Activity Of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) XPO1/CRM1 Antagonist In Patients (pts) With Relapsed / Refractory Multiple Myeloma (MM) Or Waldenstrom's Macroglobulinemia (WM)
Authors
Chen CI; Gutierrez M; Brown PDN; Gabrail N; Baz R; Reece DE; Savona M; Trudel S; Siegel DS; Mau-Sorensen M
Volume
122
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 15, 2013
Name of conference
55th Annual Meeting of the American-Society-of-Hematology
Conference place
New Orleans, LA
Conference start date
December 7, 2013
Conference end date
December 10, 2013
Conference proceedings
BLOOD
Issue
21
ISSN
0006-4971